Compare LOVE & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOVE | QSI |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.2M | 161.8M |
| IPO Year | 2018 | N/A |
| Metric | LOVE | QSI |
|---|---|---|
| Price | $17.50 | $1.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $25.00 | $1.00 |
| AVG Volume (30 Days) | 428.7K | ★ 4.0M |
| Earning Date | 03-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $697,115,000.00 | N/A |
| Revenue This Year | $4.63 | N/A |
| Revenue Next Year | $6.40 | $618.07 |
| P/E Ratio | $62.63 | ★ N/A |
| Revenue Growth | ★ 2.42 | N/A |
| 52 Week Low | $10.33 | $0.69 |
| 52 Week High | $21.90 | $3.10 |
| Indicator | LOVE | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 76.79 | 60.42 |
| Support Level | $17.41 | $0.90 |
| Resistance Level | $20.58 | $1.03 |
| Average True Range (ATR) | 0.76 | 0.06 |
| MACD | 0.28 | 0.04 |
| Stochastic Oscillator | 84.14 | 68.65 |
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.